Emma Titmuss

15PUBLICATIONS
87CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 27, 2026
Genomic Landscape of Gastroenteropancreatic Neuroendocrine Neoplasms Using Panel Sequencing.

|Oct 02, 2026
Tumor-Free Circulating Tumor DNA in Node-Negative Rectal Cancers Undergoing Neoadjuvant Chemotherapy, Excision, and Observation in the Phase II NEO Trial (CO.28).

|Dec 05, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss

|May 16, 2024
Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.

Rebecca J Deyell, Yaoqing Shen, Emma Titmuss

|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree, Emma Titmuss, James T Topham

|Apr 26, 2024
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors.

Emma Titmuss, Irene S Yu, Erin D Pleasance

Pageof 3

Frequent Collaborators

10 joint publications

Steven J M Jones

9 joint publications

Marco Marra

8 joint publications

Jonathan M Loree

7 joint publications

Karen L Mungall